Treatment Study of Anemia Associated with Chronic Kidney Disease(CKD) in Children and Adolescents Requiring or Not Requiring Dialysis

Summary

This study is for children age between 6 months and 17 years who have chronic kidney disease and proteinuria to take part in a 6 months long clinical research study. The primary purpose of this clinical research study is to learn more about an investigational study medicine called finerenone.
Individuals will be evaluated to determine their eligibility to participate in this study. Each patient who qualifies will receive the investigational medication, as well as study-related medical exams and study-related laboratory tests, at no cost. Compensation for time and travel may also, be available.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 0 to 17

Inclusion criteria:

You or your child may be eligible to participate in this trial if you or your child:
- age between 6 months and 17 years
- have been diagnosed with chronic kidney disease and proteinuria
Doctors will also evaluate other criteria to make sure you or your child qualify for the study.

Exclusion criteria:

You or your child may not be eligible to participate in this trial if you or your child:
- female who is breastfeeding or pregnant
- have kidney transplant
Doctors will also evaluate other criteria to make sure your child qualify for the study.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Please contact study coordinator Iris at Iris.Grisaru1@ucalgary.ca or 403-400-6095

Principal investigator:

Silviu Grisaru

Clinical trial:

Yes

REB-ID:

REB22-0879